Breaking News, Promotions & Moves

APEIRON Appoints CMSO

Dr. Anderson Gaweco joins from Innovimmune Biotherapeutics where he was founder, chief executive & scientific officer

APEIRON Biologics AG has appointed Anderson Gaweco, M.D., Ph.D. as its chief medical and scientific officer (CMSO). Dr. Gaweco will lead APEIRON’s rapidly advancing immuno-oncology programs and oversee the discovery, clinical and medical functions of the Company’s growing new molecular entities pipeline of innovative cancer immunotherapies. Dr. Gaweco has a successful worldwide track record across the full lifecycle of drug development from discovery through commercialization both in the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters